@kakape.bsky.social
science journalist. author. molecular biologist. curious. interested in #microbes, #misinformation and all things #blue contributing correspondent at @science.org co-host of @pandemia.bsky.social 2024 KSJ fellow at MIT Signal: kakape.93
@biorxiv-neursci.bsky.social
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@curedravet.bsky.social
The mission of DSF is to raise funds for research into Dravet syndrome and related epilepsies, while offering support to patients and families. https://dravetfoundation.org
@epilepsiajournal.bsky.social
Epilepsia® – A Journal of the ILAE Epilepsia® is the world's leading journal of original scientific research and commentary in epileptology. Impact Factor: 6.6. Epilepsia® publishes original articles on all aspects of epilepsy, clinical and experimental. T
@amepilepsysoc.bsky.social
Official account for American Epilepsy Society. We support research + education for professionals working towards a world without epilepsy. RPs ≠ endorsements.
@fda.gov
Yes, it’s really us! Our posts are FDA-approved! Visit us at https://www.fda.gov
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@jaredwhitlock.bsky.social
features editor @endpts.com / fall 2021 fellow @ksjatmit.bsky.social Writing (and editing) stories on rare disease medicine, diagnostics and China Reach out privately on Signal: jaredwhitlock.73
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app